Abstract Case 1: A 39-year-old woman with schizophrenia, obesity, hypertension and dyslipidemia was admitted to our hospital for deteriorating serum Cr level, from 97.2 to 645.3 lmol/l. She had been started on losartan 5 months earlier. After suspension of losartan and infusion of saline, her serum Cr level gradually recovered and she was discharged. Unfortunately, her physician restarted her on losartan, and 5 months after this discharge, her serum Cr level rose again to 194.5 lmol/l; again, serum Cr promptly recovered when losartan was discontinued. Selfinduced vomiting after overeating, suggesting bulimia nervosa, was revealed via the detection of a remarkable reduction of chloride compared to sodium in her spot-urine sample. Case 2: A 39-year-old woman who had been diagnosed with bipolar disorder and diabetes mellitus was admitted to our hospital with suspected diabetic ketoacidosis. After improvement in her blood sugar level, olmesartan administration for hypertension was begun. Four days later, her serum Cr level had risen from 60.1 to 256.4 lmol/l. After suspension of olmesartan and infusion of saline, her serum Cr level gradually fell to normal levels. Urinalysis revealed the dissociation of sodium and chloride. During her hospitalization, habitual self-induced vomiting was discovered. The measurement of urinary electrolytes may be useful for the detection of eating disorders with self-induced vomiting; in these patients, the administration of angiotensin II receptor blockers may induce acute kidney injury.
Introduction
Eating disorders, classified as psychoneurotic diseases, are defined by abnormal eating habits that may involve either insufficient or excessive food intake, to the detriment of an individual's physical and mental health. Self-induced vomiting is frequently seen in anorexia nervosa and bulimia nervosa, the most common eating disorders. Most patients hide this habitual behavior, and are often missed. Many electrolyte and acid-base-balance abnormalities indicating acute or chronic renal dysfunction are known to appear in these patients [1] [2] [3] , but the clinical pathophysiology remains unclear.
Angiotensin II receptor blockers (ARBs), classified as renin-angiotensin-aldosterone system (RAAS) inhibitors, are widely recognized as renal protective agents as well as anti-hypertensive agents, but conversely can induce acute kidney injury (AKI) in some cases.
We experienced two cases of eating disorders in adult women in whom AKI was induced by the administration of an ARB. To our knowledge, this is the first report of ARBinduced AKI in eating disorder patients though quite a few latent cases may exist.
Case 1
A 39-year-old woman with schizophrenia had been treated by a psychiatrist for 6 years before her first visit to our hospital. In addition, she had been seeing a physician for 1 year to manage her obesity, hypertension, dyslipidemia, S. Kaneko (&) Á Y. Tsukamoto Department of Nephrology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashiku, Tokyo 174-0051, Japan e-mail: shuzo-kaneko10@ob.md.tsukuba.ac.jp and glucose tolerance impairment. Her psychiatrist had prescribed the usual psychoneurotic multi-drugs, including bromazepam, levomepromazine, triazolam, aripiprazole, and rilmazafone, and her physician had prescribed diuretics containing furosemide, bumetanide, and spironolactone for her edema. Slight renal dysfunction (serum Cr 97.2 lmol/l) had been discovered at her first visit to the physician, and the administration of losartan 50 mg per day had been started 5 months before her first visit to our hospital.
Her physician referred her to us because of remarkable elevation of her serum Cr level to 645.3 lmol/l, and she was admitted to our hospital immediately. After hospitalization, two episodes of rapid and transient elevation of her serum Cr level following losartan administration were revealed.
Physical and laboratory examination results were as follows. Her blood pressure was 116/48 mmHg, pulse rate 86 per minute, and SpO 2 99 % (room air). She was 159 cm tall and weighed 69.6 kg. No abnormalities were observed in the physical examination except obesity. On blood examination, blood urea nitrogen was 35.7 mmol/l, creatinine 919.4 lmol/l, uric acid 672.1 lmol/l, Na 140 mmol/l, K 4.7 mmol/l, Cl 92 mmol/l, Ca 2.22 mmol/l, and inorganic P 2.32 mmol/l. Her hemoglobin was 93 g/l. Immunoglobulin and complements were all within normal limits, and she was negative for antinuclear antibody, MPO-ANCA, PR3-ANCA, and anti-GBM antibody. Spot urinary pH was 6.0, and neither proteinuria nor hematuria was observed. Urine sedimentation showed no abnormalities. Urinary N-acetylb-D-glucosaminidase (NAG) was elevated to 16.3 U/l (normal: \11.4 U/l), and spot-urinary concentrations of Na, K, Cl were 46, 37.5, and 22 mmol/l, respectively, indicating a decline of chloride and a rise of potassium in relation to sodium. The fractional excretion values of sodium (FE Na) and urea (FE urea) were 2.89 and 50 %, respectively, which indicated a 'not pre-renal pattern', but this judgment lacked reliability in the context of diuretics use.
The arterial blood gas analysis (under room air) revealed pH 7.482, PCO 2 50.9 mmHg, and HCO 3 -32.6 mmol/l, which indicated alkalemia caused by metabolic alkalosis, accompanied with slight respiratory acidosis.
Abdominal computed tomography showed slight bilateral renal atrophic change, but no other abnormalities were detected. Renal calcinosis was not detected. Renal vascular Doppler ultrasound imaging showed no decline of bilateral renal blood flow.
We diagnosed AKI on top of chronic kidney disease (CKD), then discontinued administration of all diuretics and losartan, and started an intravenous drip infusion of 0.9 % saline. Afterwards, her serum-Cr level favorably declined, and urinary volume was maintained at over 2 l per day. Her serum Cr level recovered to 141.4 lmol/l 9 days after her admission to our hospital; 4 days later, she was discharged. During the hospitalization, her blood pressure was almost unchanged and slightly low, at 100-120 over 40-50 mmHg despite the suspension of losartan and all diuretics.
However, 5 months after this visit, she appeared at our hospital again with concerns about her renal function. At the time, her serum Cr level had risen, from 114.9 to 194.5 lmol/l. The administration of losartan had been restarted by her physician soon after her hospitalization ended. We recommended the prohibition of losartan and diuretics, after which her serum Cr promptly recovered. A further 8 months later, she appeared at our hospital to request a renal function exam and prescription for diuretics. At the time her serum Cr level had not worsened, but HCO 3 -was elevated at 34.0 mmol/l despite the discontinuation of her diuretic abuse. Serum K was normal at 3.9 mmol/l. Spot urinary pH was 7.5, and urinary concentrations of Na, K, Cl were 86, 28, and 14 mmol/l, respectively. Since remarkable dissociation between urinary Na and Cl was detected, we questioned her closely and confirmed her habit of self-induced vomiting after overeating, suggesting bulimia nervosa. Episodes of repeated vomiting were also confirmed from the medical notes recorded by nurses during her hospitalization. The clinical course of case 1 is shown in Fig. 1 .
Case 2
A 39-year-old woman was diagnosed with bipolar disorder and had been seeing a psychiatrist for 8 years before her Fig. 1 Clinical course of case 1. Two episodes of rapid and transient elevation of patient's serum Cr level following losartan administration before hospitalization were revealed. The patient's serum Cr level gradually recovered after suspension of losartan and all diuretics, and after starting a 0.9 % saline infusion. After discharge and resumption of losartan administration by her physician, the patient's serum Cr level rose again, and promptly recovered after suspension of losartan. At the hospital (AKI condition), patient's spoturinary concentrations of electrolytes indicated a decline of chloride compared to sodium. Thirteen months later (non-AKI condition), remarkable dissociation between urinary concentrations of sodium and chloride was detected. Spot-urine pH changed over time. During hospitalization, urine pH was at 6.0 on admission, rose to 8.5 on day 2, and returned to 6.0 on day 9. Thirteen months later (non-AKI condition), urine pH was at 7.5 first visit to our hospital. She had been prescribed psychoneurotic multi-drugs including escitalopram, paroxetine, eszopiclone, flunitrazepam, ramelteon, lormetazepam, nitrazepam, aripiprazole, and duloxetine. She had also seen a physician for diabetes mellitus, and had been prescribed metformin and insulin aspart.
She was referred to our hospital by her physician for suspicion of diabetic ketoacidosis and was admitted because of hyperglycemia and positive ketone bodies in urinalysis. On admission, her blood pressure was 160/90 mmHg, pulse rate was 107 per minute, and SpO 2 99 % (room air). She was 158 cm tall and weighed 67.3 kg. No abnormalities were observed in her physical examination except obesity. Her blood examination revealed blood urea nitrogen of 6.60 mmol/l, creatinine 60.1 lmol/l, uric acid 398.5 mmol/l, Na 137 mmol/l, K 4.0 mmol/l, and Cl 92 mmol/l, and her blood sugar was high at 19.2 mmol/l. Spot urinalysis revealed pH 7.0, sugar 4?, and ketone body 2?. Neither proteinuria nor hematuria was observed. Urine sedimentation showed no abnormalities. Spot-urinary concentrations of Na, K, Cl were 62, 49, and 31 mmol/l, respectively, indicating a decline of chloride and a rise in potassium in relation to sodium. The arterial blood gas analysis (under room air) revealed pH 7.483, PCO 2 35.8 mmHg, HCO 3 -26.5 mmol/l, anion gap 19, and a corrected HCO 3 -(Danion gap ? HCO 3 -) of 33.5 mmol/l, which indicated metabolic alkalosis combined with high-anion-gap metabolic acidosis. Treatment with an intravenous drip and insulin infusion promptly improved her blood sugar level.
Administration of olmesartan 20 mg per day was started for hypertension. Four days later, her serum Cr and BUN levels had become drastically elevated to 256.4 lmol/l and 19.24 mmol/l, respectively, and serum K was rather low at 2.9 mmol/l. Spot urinary NAG was elevated to 53.6 U/l (normal: \11.4 U/l), and concentrations of urinary Na, K, Cl were 33, 17.5, and 17 mmol/l, respectively. Her kidneys were of normal size and shape, and ultrasonography revealed normal renal blood flow. We discontinued the administration of olmesartan, and started an intravenous drip infusion of 0.9 % saline. Her serum Cr level dropped, reaching 66.3 lmol/l 9 days after the suspension of olmesartan. Later, her habitual act of inducing vomiting by thrusting her fingers into her throat after overeating during hospitalization was revealed. Her blood pressure was transiently elevated at 150/90 mmHg just after vomiting, but almost constant at 110-120 over 70-80 mmHg, even after the suspension of olmesartan.
She was transferred to a psychoneurotic hospital for adjustment of medication. The clinical course of case 2 is shown in Fig. 2 .
Discussion
Eating disorders are often missed because patients tend to conceal their discharge habits, including self-induced vomiting and the abuse of diuretics or laxatives. Bulimic habits in both of the present patients had been missed despite regular follow-ups by psychiatrists. Both of the present patients had been administered multiple psychoactive drugs, but none of the drugs have been reported to induce AKI without breaking out of neuroleptic malignant syndrome or serotonin syndrome, leading to rhabdomyolysis. Furthermore, none of the drugs has been reported to interact with ARBs even if a common metabolic pathway (i.e. losartan in case 1 is metabolized by cytochrome P450 in the liver) exists.
Hypokalemia and metabolic alkalosis are the most common electrolyte and acid-base balance abnormalities in eating disorders [1] [2] [3] . These abnormalities are described as pseudo-Bartter's syndrome, caused by the abuse of diuretics or laxatives and self-induced vomiting, followed by secondary RAAS activation. RAAS abnormality in anorexia nervosa has been occasionally reported. In studies with small numbers of patients, the activation of adrenal aldosterone responses to angiotensin II injection [4] , or of both renin and aldosterone responses after walking [5] have been reported. Conversely, decreased vascular responsiveness to angiotensin II in untreated anorexia nervosa [6] was also reported by the same group. Fig. 2 Clinical course of case 2. At the hospital, patient's spoturinary concentrations of electrolytes indicated a deficit of chloride compared to sodium. Four days after the administration of olmesartan, patient's serum Cr level rapidly rose. After suspension of olmesartan and the start of a 0.9 % saline infusion, the patient's serum Cr level gradually recovered. Urinalysis revealed the dissociation between sodium and chloride even at the AKI condition. After therapy (i.e. infusion of 0.9 % saline), urinary concentrations of sodium and chloride became almost iso-equivalent. Spot-urine pH changed over time. Urine pH was high at 7.0 despite ketonuria on admission, and decreased to 5.5 at AKI condition (4 days after the administration of olmesartan), then returned to 6.5, 5 days after suspension of olmesartan and the start of the 0.9 % saline infusion Both of the present patients showed metabolic alkalosis, and in case 1, diuretics were administered.
The case 2 patient showed a normal serum potassium level at admission combined with high-anion-gap metabolic acidosis, but the patient's serum potassium level declined later despite the AKI state, which is suggestive of RAAS activation and chronic metabolic alkalosis.
In these cases, the most important clue to detecting selfinduced vomiting was the significant dissociation between urinary concentrations of sodium and chloride. In usual diets, sodium and chloride are ingested almost iso-equivalently as 'table salt' while potassium is an iso-equivalent of organic anions (in fruit and vegetables etc). Therefore, sodium and chloride are normally excreted almost isoequivalently, following the homeostasis of body fluids. In this steady state, all excretions (i.e. urine, sweat and faeces) contain close to iso-equivalent concentrations of sodium and chloride. On the other hand, in the 'acute phase' (which is equal to 'not having yet reached the steady state') of relative chloride loss (i.e. rapid sweat loss, subacute to acute phase of vomiting, or chloride-losing diarrhea), urinalysis shows a reduction of chloride compared to sodium. We assumed that the present cases of urinary chloride depletion in the AKI state were mainly caused by acute or subacute vomiting. In metabolic alkalosis induced by vomiting, sequential changes of renal tubular function lead to dramatic changes of urinary electrolytes and pH. In the acute phase of vomiting, elevated bicarbonate filtrate results in urinary bicarbonate excretion, leading to high urine pH and a relative excess of sodium excretion (which is induced by the electrical drag of bicarbonate). If the bicarbonate reabsorptive capacity increases to reach a level that allows for most of the filtrated bicarbonate to be reabsorbed, urinary sodium excretion decreases close to the iso-equivalent level of chloride, and H ? excretion conversely increases, leading to low urine pH (which is so called 'paradoxical aciduria'). As for urinary excretion of chloride, especially in a chloride-depletion state, transcellular reabsorption via the chloride-bicarbonate exchanger (known as pendrin, encoded by the SLC26A4 gene) at the apical membrane of beta-intercalated cells in connecting tubules and cortical collecting ducts is thought to play a quantitatively greater role [7, 8] . In case 1, urinary electrolytes were measured at two points (shown in Fig. 1 ): at first admission, and at 13 months after hospitalization. Urinalysis suggested that the former was at the subacute or near-chronic phase from vomiting, and the latter was at the acute phase. In case 1, a rapid elevation of urine pH occurred after saline infusion, suggesting that increased bicarbonate secretion had been achieved by rapid chloride replacement under the strong activation of the chloride bicarbonate exchanger of beta-intercalated cells. In case 2, the conditions of urinary electrolytes were measured at three points (shown in Fig. 2) : namely, at first admission, at AKI condition, and 4 days after starting saline infusion and suspension of ARB. Urinalysis suggested that these three readings were at the subacute to near-acute phase, at the chronic phase, and at the recovery phase, respectively. It seems that both cases showed normal renal physiological responses for vomiting even in the AKI condition, suggesting that renal tubular damage was not serious. From another point of view, both of the present cases showed low urine pH in the AKI condition under ARBs administration, suggesting that ARBs may play a role in lowering urine pH. This interesting observation is supported by the previous finding that angiotensin II inhibits H ? -ATPase in the cortical collecting ducts, contributing to reducing tubular H ? secretions, and that ARB blocked this effect [9] . Eating disorders carry a high risk of renal dysfunction. Most incidents of AKI in these patients have been reported as pre-renal dysfunction caused by volume depletion and circulating insufficiency, or parenchymal injury caused by rhabdomyolysis, in turn induced by hypokalemia or circulating insufficiency [1] [2] [3] . CKD has also been reported in these patients, which are assumed to have been induced by chronic hypokalemia following tubulointerstitial damage or potential metabolic and hemodynamic effects [3, 10] . Duration of illness and abuse of diuretics or laxatives have been reported as risk factors of CKD and the decline of the glomerular filtration rate (GFR) [11] . Nephrolithiasis or nephrocalcinosis accompanied by CKD have been reported in these patients [12, 13] . In the present cases, there were no signs of clinical circulating insufficiency even in the AKI state. In the case 1 patient, CKD was diagnosed with only slight abnormalities of urinalysis, which we assumed stemmed from tubulointerstitial damage by abuse of diuretics or/and potential metabolic and hemodynamic effects.
Risk factors of AKI induced by the administration of RAAS inhibitors have been reported as dehydration, advanced age, CKD (i.e. decline of GFR), renal vascular stenosis, and other agents (i.e. diuretics, non-steroid antiinflammatory drugs, contrast agents, etc). These conditions are favorable for RAAS inhibitors to induce AKI, because the compensatory mechanism, which is the contraction of efferent arterioles by the action of angiotensin II, might prevent kidneys from the decline of GFR. In habitualvomiting patients, two major pathophysiological conditions might exist. The first is the continual repeated volume depletion and subsequent RAAS activation, and the second is chronic chloride loss. The former involves a high risk of AKI induced by RAAS inhibition. As for the latter, the mechanism of tubulo-glomerular feedback, which acts by sensing chloride in the lumen of distal tubules, might maximally contribute to maintaining GFR. Consequently, in this condition, kidneys might have poor capacity to compensate for decline of GFR. In our cases, ARB appeared to have a harmful influence on GFR, and thereby developed into tubular damage.
Hypertensive patients without proteinuria tend to have nephrosclerosis (which is associated with glomerular hypotension); the superiority of RAAS inhibitors to Ca channel blockers concerning kidney protection has not been convincingly proved [14] . Both of the present cases had no proteinuria and case 1 had already been given large amounts of diuretics. Administration of Ca channel blockers (which are safer even in patients without eating disorders) instead of ARB, or starting ARB from a smaller dose could have avoided the development of AKI.
Conclusion
We conclude that it is important to include eating disorders in the differential diagnosis when a patient presents with AKI after starting ARBs. We suggest that RAAS inhibitors should not be used to manage hypertension or renal dysfunction in these eating disorder patients. If administration of RAAS inhibitors has been started in these patients after their condition has stabilized, electrolyte levels in spoturinalysis may be beneficial for the evaluation of AKI risk.
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